company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,116479000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4103000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2179000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,122761000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3564000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,935000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,935000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,,totalassets,Total Assets,=,debit,usd,127260000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7656000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,891000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5126000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2850000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16523000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8668000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16526000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36173000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,52696000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,248785000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-174221000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,74564000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,74564000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,74564000.0
Acceleron Pharma Inc,XLRN,,0001280600,2013.0,Q3,,2013-09-30,2013-11-14 12:09:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,127260000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,214135000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2633000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1685000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,218453000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3674000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,913000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,913000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,,totalassets,Total Assets,=,debit,usd,223040000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2295000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4659000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2234000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9188000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7453000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,25942000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,33395000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42583000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,381901000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-201444000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,180457000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,180457000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,180457000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q1,,2014-03-31,2014-05-15 09:01:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,223040000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,204250000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3731000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2180000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,210161000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3581000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,902000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,902000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,,totalassets,Total Assets,=,debit,usd,214644000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2614000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6475000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2004000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5000000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16093000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7212000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,21512000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,28724000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,44817000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,387822000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-217995000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,169827000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,169827000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,169827000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q2,,2014-06-30,2014-08-12 12:49:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,214644000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,189256000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3228000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3947000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,196431000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3379000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,902000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,902000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,,totalassets,Total Assets,=,debit,usd,200712000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3314000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5938000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1860000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11112000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6951000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15028000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21979000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33091000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,393587000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-225966000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,167621000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,167621000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,167621000.0
Acceleron Pharma Inc,XLRN,,0001280600,2014.0,Q3,,2014-09-30,2014-11-07 09:28:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,200712000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39814000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,61329000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4049000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2576000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,107768000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2949000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,63885000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,971000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,64856000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,,totalassets,Total Assets,=,debit,usd,175573000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1567000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6692000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1523000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9782000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6295000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,13702000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,29779000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,403993000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-258156000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,145794000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,145794000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,145794000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q1,,2015-03-31,2015-05-07 07:26:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,175573000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38156000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,75798000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5286000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1773000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,121013000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2902000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,42641000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,962000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,43603000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,,totalassets,Total Assets,=,debit,usd,167518000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1790000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8377000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1271000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11438000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10680000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16677000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,28115000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,408002000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-268537000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-62000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,139403000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,139403000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,139403000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q2,,2015-06-30,2015-08-06 07:31:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,167518000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43438000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,72459000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3950000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2536000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,122383000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2945000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,32253000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,839000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,33092000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,,totalassets,Total Assets,=,debit,usd,158420000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2647000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8968000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1257000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12872000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5696000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8064000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,13760000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,26632000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,412204000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-280395000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-21000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,131788000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,131788000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,131788000.0
Acceleron Pharma Inc,XLRN,,0001280600,2015.0,Q3,,2015-09-30,2015-11-04 07:40:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,158420000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,63681000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,100784000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3057000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3165000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,170687000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3724000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,114188000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1003000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,115191000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,,totalassets,Total Assets,=,debit,usd,289602000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1202000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12678000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1299000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15179000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5642000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8504000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14146000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,29325000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,562669000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-302417000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,260277000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,260277000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,260277000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q1,,2016-03-31,2016-05-05 08:35:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,289602000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36995000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,83724000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3239000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3081000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,127039000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4190000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,141997000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1004000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,143001000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,,totalassets,Total Assets,=,debit,usd,274230000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,566000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11824000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1303000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13693000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5313000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11368000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16681000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,30374000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,568037000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-324433000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,252000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,243856000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,243856000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,243856000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q2,,2016-06-30,2016-08-04 17:01:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,274230000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31016000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,107279000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3019000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3676000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,144990000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4215000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,112728000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,952000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,113680000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,,totalassets,Total Assets,=,debit,usd,262885000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2071000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12814000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1307000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16192000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4985000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12161000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17146000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33338000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,574872000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-345203000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-122000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,229547000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,229547000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,229547000.0
Acceleron Pharma Inc,XLRN,,0001280600,2016.0,Q3,,2016-09-30,2016-11-03 16:21:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,262885000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33157000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,108220000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3570000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4086000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,149033000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7107000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,71837000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1152000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,72989000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,,totalassets,Total Assets,=,debit,usd,229129000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,911000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12968000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1314000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15193000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4327000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5616000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20809000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,598697000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-389977000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-400000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,208320000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,208320000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,208320000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q1,,2017-03-31,2017-05-08 08:00:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,229129000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30726000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,111695000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2881000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3111000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,148413000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7210000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,51617000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1223000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,52840000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,,totalassets,Total Assets,=,debit,usd,208463000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1661000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11370000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1268000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14299000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4116000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1516000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5632000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19931000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,608532000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-419646000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-354000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,188532000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,188532000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,188532000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q2,,2017-06-30,2017-08-03 16:13:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,208463000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,238959000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,98266000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2879000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3334000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,343438000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7211000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,29372000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1256000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30628000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,,totalassets,Total Assets,=,debit,usd,381277000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1024000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14141000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,719000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15884000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4925000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1927000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6852000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22736000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,803952000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-445097000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-314000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,358541000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,358541000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,358541000.0
Acceleron Pharma Inc,XLRN,,0001280600,2017.0,Q3,,2017-09-30,2017-11-07 07:09:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,381277000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,69736000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,222119000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3232000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5203000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,300290000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7019000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,61488000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1237000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,62725000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,,totalassets,Total Assets,=,debit,usd,370034000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1677000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11079000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,186000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12942000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1992000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1320000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3312000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16254000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,850643000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-495539000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1324000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,353780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,353780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,353780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q1,,2018-03-31,2018-05-08 16:19:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,370034000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,79592000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,208338000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3669000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7517000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,299116000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6868000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44328000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1229000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45557000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,,totalassets,Total Assets,=,debit,usd,351541000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1269000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13113000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,190000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14572000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2171000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1689000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3860000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18432000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,858629000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-524477000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1043000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,333109000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,333109000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,333109000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q2,,2018-06-30,2018-08-02 16:22:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,351541000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,112427000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,195545000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3258000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7093000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,318323000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6270000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,11835000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1689000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13524000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,,totalassets,Total Assets,=,debit,usd,338117000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1289000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13144000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,248000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14681000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2293000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2031000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4324000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19005000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,871690000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-551815000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-763000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,319112000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,319112000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,319112000.0
Acceleron Pharma Inc,XLRN,,0001280600,2018.0,Q3,,2018-09-30,2018-10-30 16:13:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,338117000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,214490000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,223106000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2780000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7897000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,448273000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7027000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,75509000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,29521000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,105030000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,,totalassets,Total Assets,=,debit,usd,560330000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5537000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3930000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13803000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23270000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,24918000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1607000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,26525000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49795000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1135429000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-624602000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-292000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,510535000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,510535000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,510535000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q1,,2019-03-31,2019-05-09 16:12:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,560330000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,163609000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,267151000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5447000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9508000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,445715000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6775000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,70156000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,28222000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,98378000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,,totalassets,Total Assets,=,debit,usd,550868000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5746000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3548000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16762000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,26056000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,23407000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1508000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24915000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,50971000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1142201000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-642464000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,160000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,499897000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,499897000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,499897000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q2,,2019-06-30,2019-08-05 16:11:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,550868000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,169542000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,256529000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6875000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10588000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,443534000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6852000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,42218000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27063000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,69281000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,,totalassets,Total Assets,=,debit,usd,519667000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5961000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1854000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23825000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31640000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,21852000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1374000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,23226000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,54866000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1152503000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-687833000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,131000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,464801000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,464801000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,464801000.0
Acceleron Pharma Inc,XLRN,,0001280600,2019.0,Q3,,2019-09-30,2019-11-06 07:57:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,519667000.0
